NUTEX — Nutex Befektetesi Nyrt Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual income statement for Nutex Befektetesi Nyrt, fiscal year end - December 31st, HUF millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.45	0.45	0.45	0.45	0.45
Cost of Revenue
Gross Profit	—	—	0.45	0.45	0.45
Selling / General / Administrative Expenses
Other Operating Expenses
Total Operating Expenses	13.6	16.4	21.5	97.6	112
Operating Profit	-13.1	-16	-21.1	-97.1	-112
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	13.3	139	178	466	543
Provision for Income Taxes
Net Income After Taxes	12.7	134	171	423	494
Minority Interest
Net Income Before Extraordinary Items
Net Income	12.7	134	171	423	494
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	12.7	134	171	423	494
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.086	0.902	1.16	2.86	3.8
Dividends per Share